CD8A and neoplasm: In this study, BEMPEG also inhibited primary tumor growth and metastatic relapse in the lungs and bone tissue after K7M3 primary tumor resection, with a concurrent increase in CD8+ and CD4+ T‐cell infiltration in the bone and lungs.